1. Home
  2. FRES vs ATCH Comparison

FRES vs ATCH Comparison

Compare FRES & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRES
  • ATCH
  • Stock Information
  • Founded
  • FRES 2010
  • ATCH 2022
  • Country
  • FRES United States
  • ATCH United States
  • Employees
  • FRES N/A
  • ATCH N/A
  • Industry
  • FRES Medical Specialities
  • ATCH
  • Sector
  • FRES Health Care
  • ATCH
  • Exchange
  • FRES Nasdaq
  • ATCH Nasdaq
  • Market Cap
  • FRES 6.4M
  • ATCH 5.8M
  • IPO Year
  • FRES 2020
  • ATCH N/A
  • Fundamental
  • Price
  • FRES $1.85
  • ATCH $0.21
  • Analyst Decision
  • FRES
  • ATCH
  • Analyst Count
  • FRES 0
  • ATCH 0
  • Target Price
  • FRES N/A
  • ATCH N/A
  • AVG Volume (30 Days)
  • FRES 4.8K
  • ATCH 272.0K
  • Earning Date
  • FRES 09-17-2024
  • ATCH 09-17-2024
  • Dividend Yield
  • FRES N/A
  • ATCH N/A
  • EPS Growth
  • FRES N/A
  • ATCH N/A
  • EPS
  • FRES N/A
  • ATCH 0.04
  • Revenue
  • FRES $2,341,326.00
  • ATCH N/A
  • Revenue This Year
  • FRES N/A
  • ATCH N/A
  • Revenue Next Year
  • FRES N/A
  • ATCH N/A
  • P/E Ratio
  • FRES N/A
  • ATCH $4.60
  • Revenue Growth
  • FRES 94.50
  • ATCH N/A
  • 52 Week Low
  • FRES $1.55
  • ATCH $0.20
  • 52 Week High
  • FRES $26.00
  • ATCH $10.26
  • Technical
  • Relative Strength Index (RSI)
  • FRES 43.57
  • ATCH 44.77
  • Support Level
  • FRES $1.58
  • ATCH $0.20
  • Resistance Level
  • FRES $2.01
  • ATCH $0.25
  • Average True Range (ATR)
  • FRES 0.17
  • ATCH 0.03
  • MACD
  • FRES 0.05
  • ATCH 0.01
  • Stochastic Oscillator
  • FRES 62.50
  • ATCH 74.64

About FRES Fresh2 Group Limited

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

Share on Social Networks: